| ID | 68750 |
| Title Alternative | 原発性乳癌に対する術前化学療法の効果予測因子として腸内細菌叢の有用性の検討：多施設共同前向きコホート研究（SBP-14）
|
| FullText URL | |
| Author |
NAKAMOTO, Shogo
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
|
| Note | 岡山大学審査学位論文
This is an Accepted Manuscript of the article: Nakamoto, S., Kajiwara, Y., Taniguchi, K. et al. Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14. Breast Cancer Res Treat 208, 67–77 (2024). https://doi.org/10.1007/s10549-024-07395-7
This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s10549-024-07395-7
|
| Published Date | 2025-03-25
|
| Content Type |
Thesis or Dissertation
|
| Grant Number | 甲第7190号
|
| Granted Date | 2025-03-25
|
| Thesis Type |
Doctor of Philosophy in Medical Science
|
| Grantor | 岡山大学
|
| Thesis FullText |
Thesis or Dissertation (See FullText URL)
|
| Related Url | isVersionOf https://doi.org/10.1007/s10549-024-07395-7
|
| language |
English
|
| File Version | ETD
|
| Grant ID | 15301甲第7190号
|
| PubMed ID | |
| Copyright Holders | © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024
|
| DOI |
